Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Development of an In Vitro Screening Assay for Compounds that Increase Bone Formation.

Hahn SE, Yu M, Tong S, Geisterfer-Lowrance AA, Sindrey D, Lee DK.

J Biomol Screen. 1999;4(6):363-372.

PMID:
10838433
2.

A mouse model of familial hypertrophic cardiomyopathy.

Geisterfer-Lowrance AA, Christe M, Conner DA, Ingwall JS, Schoen FJ, Seidman CE, Seidman JG.

Science. 1996 May 3;272(5262):731-4.

PMID:
8614836
3.

Production of homozygous mutant ES cells with a single targeting construct.

Mortensen RM, Conner DA, Chao S, Geisterfer-Lowrance AA, Seidman JG.

Mol Cell Biol. 1992 May;12(5):2391-5.

4.

A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG.

Cell. 1990 Sep 7;62(5):999-1006.

PMID:
1975517
5.

A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436, and CRI-L329 on chromosome 14 at q11-q12.

Solomon SD, Geisterfer-Lowrance AA, Vosberg HP, Hiller G, Jarcho JA, Morton CC, McBride WO, Mitchell AL, Bale AE, McKenna WJ, et al.

Am J Hum Genet. 1990 Sep;47(3):389-94.

Supplemental Content

Loading ...
Support Center